| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |